Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Brook B Cole"'
Autor:
Brook B. Cole, Susan D. Reynolds, Paul R. Reynolds, Brian B. Graham, Kimberly M. Jenkins, Russell W. Smith
Publikováno v:
The American Journal of Pathology. 177:362-376
Analysis of lineage relationships in the naphthalene-injured tracheal epithelium demonstrated that two multipotential keratin 14–expressing cells (K14ECs) function as progenitors for Clara and ciliated cells. These K14EC were distinguished by their
Publikováno v:
Tissue Engineering. 13:1025-1034
Chondrogenesis of human mesenchymal stem cells (hMSCs) encapsulated in poly(ethylene glycol) (PEG)-based hydrogels was studied in the presence and absence of 5 ng/mL transforming growth factor beta and chondrogenic medium to better understand the rol
Autor:
Susan D. Reynolds, Moumita Ghosh, Heather M. Brechbuhl, Bilan Li, Paul R. Reynolds, Brook B. Cole, Russel W. Smith, Mary Kathryn Smith, Douglas A. Hicks
Publikováno v:
C27. GENETIC PROGRAMS DRIVING LUNG DEVELOPMENT AND REGENERATION.
Autor:
Paul R. Reynolds, Brook B. Cole, Douglas A. Hicks, Russell W. Smith, Bilan Li, Mary Kathryn Smith, Moumita Ghosh, Heather M. Brechbuhl, Susan D. Reynolds
Publikováno v:
The American journal of pathology. 179(1)
The purpose of this study was to determine whether β-catenin regulates basal cell fate determination in the mouse trachea. Analysis of TOPGal transgene reporter activity and Wnt/β-catenin pathway gene expression suggested a role for β-catenin in b
Autor:
Brook B, Cole, Russell W, Smith, Kimberly M, Jenkins, Brian B, Graham, Paul R, Reynolds, Susan D, Reynolds
Publikováno v:
The American journal of pathology. 177(1)
Analysis of lineage relationships in the naphthalene-injured tracheal epithelium demonstrated that two multipotential keratin 14–expressing cells (K14ECs) function as progenitors for Clara and ciliated cells. These K14EC were distinguished by their
Publikováno v:
Tissue Engineering; May2007, Vol. 13 Issue 5, p1025-1034, 10p
Autor:
Tanisha Meeuwsen, Laurence H. Hurley, Emmanuel T. Akporiaye, Disis L Mary, Hailing Lu, Deborah Bradley-Dunlop, Manuel L. Penichet, Daniel D. VonHoff, David G. Besselsen, Tobias Hahn, Brook B Cole, Stephen T. Gately, Edwin B. Walker
Publikováno v:
Hahn, Tobias; Bradley-Dunlop, Deborah J; Hurley, Laurence H; Von-Hoff, Daniel; Gately, Stephen; Mary, Disis L; et al.(2011). The vitamin E analog alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer. BMC Cancer, 11(1), 471. doi: http://dx.doi.org/10.1186/1471-2407-11-471. Retrieved from: http://www.escholarship.org/uc/item/2mm6f5hj
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 471 (2011)
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 471 (2011)
Background HER2/neu is an oncogene that facilitates neoplastic transformation due to its ability to transduce growth signals in a ligand-independent manner, is over-expressed in 20-30% of human breast cancers correlating with aggressive disease and h
Autor:
Lue HW; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA., Cole B; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA., Rao SA; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA., Podolak J; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA., Van Gaest A; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA., King C; Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA., Eide CA; Hematology and Oncology, Oregon Health and Science University, Portland, OR 97239, USA.; Howard Hughes Medical Institute, Oregon Health and Science University, Portland, OR 97239, USA., Wilmot B; Oregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, OR 97239, USA., Xue C; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA., Spellman PT; Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR 97239, USA., Heiser LM; Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA., Tyner JW; Hematology and Oncology, Oregon Health and Science University, Portland, OR 97239, USA.; Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR 97239, USA., Thomas GV; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA.; Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
Publikováno v:
Oncotarget [Oncotarget] 2015 Dec 29; Vol. 6 (42), pp. 44675-87.